Fill Finish Manufacturing Market

The fill finish manufacturing market is projected to reach USD 30.37 billion by 2031, up from USD 19.75 billion in 2026, at a CAGR of 9.0%. The growth of the fill finish manufacturing market is driven by the biosimilars & ADC pipeline expansion, which drives sterile injectable contract manufacturing growth. Additionally, EU GMP Annex 1 compliance & global sterile manufacturing regulatory harmonization driving capital investments for isolators and RABS are expected to support market growth.

The global fill finish manufacturing market is consolidated, with top players such as West Pharmaceutical Services, Inc. (US), BD & Co (US), Syntegon Technology GmbH (Germany), I.M.A. S.P.A. (Italy), and Gerresheimer AG (Germany) leading the market. The market players have adopted various strategies, including approvals and launches of new products, acquisitions, agreements, collaborations, partnerships, and geographic expansions, to strengthen their positions in the global fill finish manufacturing market.   

To know about the assumptions considered for the study download the pdf brochure

West Pharmaceutical Services, Inc. (US)

West Pharmaceutical Services is a leading provider of injectable drug packaging, containment, and delivery solutions supporting sterile fill-finish manufacturing. Its portfolio includes prefillable syringes, vials, cartridges, and closure systems designed to ensure drug integrity and patient safety. The company continues to strengthen its market position through innovation, highlighted by the 2025 launch of the PLASCAP metal-free vial closure for aseptic manufacturing applications.

BD & Co. (US)

BD & Co. (Becton, Dickinson and Company) is a leading provider of drug delivery and fill-finish solutions, offering prefillable syringes, wearable injectors, self-injection systems, and advanced containment technologies for biologics and injectable therapies. The company strengthens its market position through continuous innovation, global manufacturing capabilities, and strategic partnerships. In 2025, BD announced the first pharma-sponsored clinical trial utilizing its BD Libertas Wearable Injector technology for biologic drug delivery, further expanding its presence in advanced drug delivery solutions.

Syntegon Technology GmbH (Germany)

Syntegon Technology is a leading provider of pharmaceutical processing and fill-finish equipment, offering advanced aseptic filling systems, isolators, inspection technologies, and integrated packaging solutions for sterile injectables, biologics, and vaccines. The company focuses on automation, contamination control, and flexible manufacturing technologies to improve production efficiency. In 2024, Syntegon expanded its pharmaceutical portfolio with advanced isolator-based filling solutions and integrated line concepts designed to support the growing demand for high-value biologics and aseptic drug manufacturing.

I.M.A. S.P.A. (Italy)

I.M.A S.p.A. is a leading provider of pharmaceutical fill-finish and packaging technologies, offering aseptic filling systems, lyophilization solutions, isolators, and integrated production lines for vials, syringes, and cartridges. The company focuses on automation, contamination control, and flexible manufacturing to support sterile injectable production. In 2024, I.M.A Life expanded its aseptic processing portfolio with advanced robotic filling and isolator technologies designed to enhance sterility assurance and operational efficiency for biologics and high-value injectable therapies.

Market Ranking

The fill-finish manufacturing market is highly competitive, with the presence of five major players: West Pharmaceutical Services, Inc. (US), BD & Co (US), Syntegon Technology GmbH (Germany), I.M.A. S.P.A. (Italy), and Gerresheimer AG (Germany). These companies collectively account for a significant portion of the total market. These companies maintain their leading positions through strategic investments, regulatory advancements, technological innovation, and global partnerships.

West Pharmaceutical Services, Inc. (US) is a leading provider of injectable drug packaging, containment, and delivery systems. The company offers prefillable syringes, closures, and integrated solutions that support sterility, drug integrity, and patient safety. West continues to strengthen its market position through innovation, strategic collaborations, and expansion of advanced containment technologies.

Becton, Dickinson and Company (BD) (US) is a major player in drug delivery and fill-finish solutions, offering prefillable syringes, self-injection systems, and advanced containment technologies. The company focuses on innovation, manufacturing excellence, and strategic partnerships to address the growing demand for biologics and injectable therapies.

Syntegon Technology GmbH (Germany) provides advanced pharmaceutical processing and fill-finish technologies, including aseptic filling systems, isolators, and inspection solutions. The company emphasizes automation, digitalization, and sustainability to improve manufacturing efficiency and regulatory compliance.

I.M.A. S.P.A. (Italy) is a global supplier of pharmaceutical processing and packaging equipment, offering automated filling, lyophilization, and aseptic processing solutions. Its focus on modular designs, customization, and innovation enables manufacturers to address diverse sterile manufacturing requirements.

Gerresheimer AG (Germany) specializes in pharmaceutical primary packaging solutions, including high-quality syringes, vials, and cartridges. The company focuses on precision manufacturing, sustainability initiatives, and capacity expansion to support the increasing demand for injectable drugs and biologics.

The remaining share of the fill-finish manufacturing market is held by regional and emerging companies that compete through specialized technologies, strategic partnerships, capacity expansions, and customized manufacturing solutions. Growing demand for biologics, vaccines, and advanced therapies continues to create opportunities for these players.

The remainder of the market, accounting for approximately 65–70%, consists of regional suppliers and niche technology developers. These players are expanding through targeted innovation, localized collaborations, and customized fill finish manufacturing solutions tailored to academic institutions, emerging biotechnology companies, contract research organizations (CROs), and small-scale biomanufacturers requiring flexible and application-specific production capabilities.

Related Reports:

Fill Finish Manufacturing Market by Consumables (PFS [System, Plunger Stoppers, Glass, Polymer], Vials [Bulk, RTU], Vial Stoppers, Cartridges, Cell Therapy Bags), Instruments (Integrated), Type (Automated), Services, Competition - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]